[ad_1]
Coronavirus – All the news: One of the volunteers spoke about the side effects after his vaccination on the website of the British newspaper “Daily Mail”.
A volunteer who participated in clinical trials of the AstraZeneca vaccine and the University of Oxford, talks about his difficult experience.
In an exclusive interview with the British newspaper “Daily Mail”, the volunteer admitted that he was vaccinated last May.
According to the British newspaper, he did not feel well for a few hours after being vaccinated against Covid-19.
“He had a fever, headache and fatigue,” he admits.
The volunteer emphasizes that he suffered from high fever, chills, headache and fatigue 14 hours after vaccination.
However, he says he is willing to continue after clinical trials of the vaccine resume after the temporary suspension of the vaccine.
AstraZeneca: We will wait a long time for the vaccine
AstraZeneca CEO Pascal Sorio said today that it will be known before the end of the year whether the company’s experimental coronavirus vaccine offers protection to humans, provided the British-Swedish group can soon repeat the unproven clinical trials. .
AstraZeneca announced on Wednesday that Global testing of its coronavirus vaccine is suspended., which take place in many countries, following the appearance of a “possibly unexplained illness” in a volunteer.
It is said that this volunteer shows neurological symptoms associated with a rare inflammation in the spinal cord, called transverse myelitis.
Sorio stressed that it is very common to suspend research on a vaccine, but this time the difference is that everyone is watching events closely.
“In fact, it is very common and many experts can tell you,” he said. “The difference from other vaccine clinical trials is that not everyone is watching. “They stop, investigate and start over,” he explained.
AstraZeneca’s owner clarified that the pharmaceutical company does not know the clear diagnosis of the volunteer, adding that it is not clear that he has developed transverse myelitis and that further testing is needed.
Sorio said that the diagnosis will be sent to an independent safety committee, which will inform the pharmaceutical company if it can continue with clinical trials.
AstraZeneca will provide vaccines to countries simultaneously to ensure fair and equitable distribution, stressed the owner of the company. He added that the pharmaceutical industry is close to increasing its production capacity to 3 billion doses in laboratories around the world, in order to prevent governments from restricting the distribution of the vaccine.
The vaccine, developed by AstraZeneca in conjunction with the University of Oxford, was described by the World Health Organization as probably the world’s leading candidate vaccine against covid-19 and the most advanced in terms of its development.
See all the latest news from Greece and the world, as it happens, on Newsbomb.gr
Read also:
Yeni φάafak: Egypt and Turkey secretly negotiate over the Kastelorizo region
